This site is targeted at medical and radiology professionals, contains user contributed content, and material that may be confusing to a lay audience. Use of this site implies acceptance of our Terms of Use.

Bone scan

A bone scan is a nuclear medicine (scintigraphic) study that makes use of Technetium 99m (commonly Tc99m-methylene diphosphonate (MDP)) as the active agent. 

The study has three stages which follow intravenous injection of the tracer.

Clinical indications

  • malignancy : detection and follow-up of skeletal metastases
  • detection of radiographically occult fractures
  • osteomyelitis
  • reflex sympathetic dystrophy
  • hip joint prosthesis : evaluation for infection or loosening

Patient preparation

  • hydration
  • remove metal objects
  • void immediately before study

Tracer dose and route of administration

Tc99m diphosphonate is administered intravenously, at a dose of 20 mCi. 

The phases

Flow phase
  • 2 to 5-sec images are obtained for 60 seconds after injection
  • demonstrates perfusion and characterises the blood flow to a particular area
Blood pool phase
  • the blood-pool image is obtained 5 min after injection
  • demonstrated the blood pool, not the blood flow
  • inflammation causes capillary dilatation and increased blood flow

If the study is going to be a triphasic bone scan, a third phase is added.

Delayed phase
  • the bone image is obtained 2 - 4 hours later
  • urinary excretion has decreased the amount of the radionuclide in soft tissue

See also

Updating… Please wait.

 Details successfully updated.

Error Unable to process the form. Check for errors and try again.

 Thank you for updating your details.